Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications

被引:48
作者
Duque, Alice [1 ]
Mediano, Mauro Felippe Felix [1 ,2 ]
De Lorenzo, Andrea [1 ]
Rodrigues Jr, Luiz Fernando [1 ,3 ]
机构
[1] Inst Nacl Cardiol, Educ & Res Dept, Rua Laranjeiras 374, BR-22240006 Rio De Janeiro, RJ, Brazil
[2] Evandro Chagas Natl Inst Infect Dis, Oswaldo Cruz Fdn, Lab Clin Res Chagas Dis, BR-21040360 Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Inst Biomed, Dept Physiol Sci, BR-22240006 Rio De Janeiro, RJ, Brazil
关键词
Cardiovascular autonomic neuropathy; Cardiac autonomic neuropathy; Diabetes mellitus; Heart rate variability; Sympathetic autonomic nervous system; Parasympathetic autonomic nervous system; HEART-RATE-VARIABILITY; RISK-FACTORS; CARDIAC DENERVATION; OXIDATIVE STRESS; NERVOUS-SYSTEM; QT INTERVAL; MORTALITY; DIAGNOSIS; DYSFUNCTION; IMPACT;
D O I
10.4239/wjd.v12.i6.855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular autonomic neuropathy (CAN) is a debilitating condition that mainly occurs in long-standing type 2 diabetes patients but can manifest earlier, even before diabetes is diagnosed. CAN is a microvascular complication that results from lesions of the sympathetic and parasympathetic nerve fibers, which innervate the heart and blood vessels and promote alterations in cardiovascular autonomic control. The entire mechanism is still not elucidated, but several aspects of the pathophysiology of CAN have already been described, such as the production of advanced glycation end products, reactive oxygen species, nuclear factor kappa B, and pro-inflammatory cytokines. This microvascular complication is an important risk factor for silent myocardial ischemia, chronic kidney disease, myocardial dysfunction, major cardiovascular events, cardiac arrhythmias, and sudden death. It has also been suggested that, compared to other traditional cardiovascular risk factors, CAN progression may have a greater impact on cardiovascular disease development. However, CAN might be subclinical for several years, and a late diagnosis increases the mortality risk. The duration of the transition period from the subclinical to clinical stage remains unknown, but the progression of CAN is associated with a poor prognosis. Several tests can be used for CAN diagnosis, such as heart rate variability (HRV), cardiovascular autonomic reflex tests, and myocardial scintigraphy. Currently, it has already been described that CAN could be detected even during the subclinical stage through a reduction in HRV, which is a non-invasive test with a lower operating cost. Therefore, considering that diabetes mellitus is a global epidemic and that diabetic neuropathy is the most common chronic complication of diabetes, the early identification and treatment of CAN could be a key point to mitigate the morbidity and mortality associated with this long-lasting condition.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy
    Liao, X. -P.
    Zhu, H. -W.
    Zeng, F.
    Tang, Z. -H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (10): : 1075 - 1082
  • [32] Relationship between cardiovascular autonomic neuropathy and coronary artery calcification in patients with type 2 diabetes
    Moon, Seong-Su
    Choi, Yeon-Kyung
    Seo, Hyun-Ae
    Jeon, Jae-Han
    Lee, Jung-Eun
    Jeong, Ji-Yun
    Lee, Ju-Young
    Lee, Duk-Hee
    Park, Wan-Ju
    Kim, Jung-Guk
    Kim, Bo-Wan
    Lee, In-Kyu
    ENDOCRINE JOURNAL, 2010, 57 (05) : 445 - 454
  • [33] Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes
    Yun, Jae-Seung
    Park, Yong-Moon
    Cha, Seon-Ah
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [34] Permutation entropy analysis of heart rate variability for the assessment of cardiovascular autonomic neuropathy in type 1 diabetes mellitus
    Naranjo, Claudia Carricarte
    Sanchez-Rodriguez, Lazaro M.
    Brown Martinez, Marta
    Estevez Baez, Mario
    Machado Garcia, Andres
    COMPUTERS IN BIOLOGY AND MEDICINE, 2017, 86 : 90 - 97
  • [35] Cardiac autonomic neuropathy in patients with diabetes mellitus
    Dimitropoulos, Gerasimos
    Tahrani, Abd A.
    Stevens, Martin J.
    WORLD JOURNAL OF DIABETES, 2014, 5 (01) : 17 - 39
  • [36] Autonomic neuropathy in diabetes mellitus
    Verrotti, Alberto
    Prezioso, Giovanni
    Scattoni, Raffaella
    Chiarelli, Francesco
    FRONTIERS IN ENDOCRINOLOGY, 2014, 5
  • [37] Low muscle strength rather than low muscle mass is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes
    Jung, Chan-Hee
    Cho, Yoon Young
    Choi, Dug-Hyun
    Kim, Bo-Yeon
    Jung, Sang-Hee
    Kim, Chul-Hee
    Mok, Ji-Oh
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Prognostic importance of cardiovascular autonomic neuropathy on cardiovascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort
    Cardoso, Claudia R. L.
    de Oliveira, Vinicius A. G.
    Leite, Nathalie C.
    Salles, Gil F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 196
  • [39] Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
    Pan, Qi
    Li, Quanmin
    Deng, Wei
    Zhao, Dong
    Qi, Lin
    Huang, Wei
    Ma, Li
    Li, Hongmei
    Li, Yufeng
    Lyu, Xiaofeng
    Wang, Aihong
    Yao, Hebin
    Guo, Lixin
    Xing, Xiaoyan
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [40] Decreased glomerular filtration rate and increased albuminuria for identification of cardiovascular autonomic neuropathy in subjects with and without diabetes
    Lai, Ying-Chuen
    Li, Hung-Yuan
    Jiang, Yi-Dier
    Chang, Tien-Jyun
    Chuang, Lee-Ming
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2021, 230